跳至主要内容
临床试验/KCT0004228
KCT0004228进行中(未招募)未知

Benefits of ICD for the primary prEvention in patients with vAlvular cardiomyopathy

Keimyung University Dongsan Hospital0 个研究点目标入组 122 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
122

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19?(Year) 至 75?(Year)(—)
性别
All

入选标准

  • Adults 19 to 75 years
  • Patients who meet one of the following criteria:
  • ?Patients who have undergone surgery for aortic valve or mitral valve disease for more than 12 months
  • ?Patients with severe aortic valve or mitral valve disease
  • Patients with left ventricular ejection fraction = 35% by echocardiography or other imaging methods
  • US, European practice guidelines class I indication for ICD implantation
  • Patients without evidence of ischemic heart disease (who meet one of the following criteria):
  • ?Stress test negative
  • ?Significant stenosis was not observed in coronary artery images:epicardial coronary stenosis <70%, left main stenosis <50%
  • History of heart failure symptoms
  • Patients who have received medication for more than 3 months according to the heart failure treatment guideline recommendation

排除标准

  • Patients with left ventricular dysfunction without valvular heart disease
  • Patients who require cardiac pacing therapy due to bradycardia
  • Heart transplant scheduled
  • Life expectancy is less than one year

研究者

发起方
Keimyung University Dongsan Hospital

相似试验